Best Pharma Security Audit Service

In the last ten years, we’ve witnessed a dramatic rise in the number of novel disease outbreaks globally. Leading pharmaceutical companies have been working rigorously to develop newer drugs to effectively counter these threats. The relentless pressure to innovate and produce medicines has pushed major drug companies to embrace digital technology. And as the pharma industry moves towards complete digitalisation, the shadow of cyber threats now looms larger than ever. This is evident from the startling levels of sophistication in cybercrimes this millennium has seen already.

Pharmaceutical companies need to be vigilant and proactive to prevent the security breaches caused by external as well as internal actors. A failure to keep data security measures updated can prove disastrous for drug companies in several ways. The issues that can stem from weak or incoherent cyber protection include:

Patients Data Leaks
Pharmacovigilance Audit Issues
Data Compromise by Employees
Problem with Internet of Things
Chemical Terrorism

Why Industry is a target for cybercrime (Business Risks)‎

Pharma companies were effectively entrusted with ending the pandemic, making them an attractive target for hackers who wanted to steal trade secrets. This created a perfect storm for cybercrime, giving hackers both the means and the motivation to step up their criminal activities. It was just the latest iteration of a problem that has been intensifying over the last ten years. And it highlighted the critical importance of cybersecurity, particularly where public health is at stake.

Cyber-attacks: for money, fame and politics
Costs of cybercrime: the death of a company
Intellectual property theft: targeting sensitive data
Being prepared: locking the door before the horse has bolted
Beating cybercriminals: educating organisations